Literature DB >> 31969414

Hyperkinetic reaction to dihydrocodeine.

James David van Oppen1,2, Neeta Patel2, Aamir Tarique2.   

Abstract

A young man was using dihydrocodeine analgesia for ear pain having had suppurative otitis media. He attended the emergency department with restlessness and twitching movements in his arms and legs. He had fever with otherwise normal vital signs. He had no signs of cerebellar pathology. Investigations were normal. The working diagnosis was of hyperkinetic reaction to dihydrocodeine. Symptoms resolved within 48 hours of withdrawing the drug. Serotonin toxicity is a rare side effect of dihydrocodeine. There is a theoretical basis for increased side effects when taken with cannabidiol-based substances. © BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  drug interactions; emergency medicine; movement disorders (other than Parkinsons); neurology (drugs and medicines); unwanted effects / adverse reactions

Mesh:

Substances:

Year:  2020        PMID: 31969414      PMCID: PMC7035806          DOI: 10.1136/bcr-2019-233264

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  13 in total

1.  The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity.

Authors:  E J C Dunkley; G K Isbister; D Sibbritt; A H Dawson; I M Whyte
Journal:  QJM       Date:  2003-09

2.  Myoclonus associated with concomitant ciprofloxacin and oxycodone in an older patient.

Authors:  Gopinath Kango Gopal; Cassie Hewton; Shibu Krishnan Pazhvoor
Journal:  Br J Clin Pharmacol       Date:  2014-05       Impact factor: 4.335

Review 3.  Life-threatening drug interactions: what the physician needs to know.

Authors:  Richard O Day; Leone Snowden; Andrew J McLachlan
Journal:  Intern Med J       Date:  2017-05       Impact factor: 2.048

Review 4.  Hiccup and apparent myoclonus after hydrocodone: review of the opiate-related hiccup and myoclonus literature.

Authors:  E C Lauterbach
Journal:  Clin Neuropharmacol       Date:  1999 Mar-Apr       Impact factor: 1.592

5.  The Potential for Pharmacokinetic Interactions Between Cannabis Products and Conventional Medications.

Authors:  Yuli Qian; Bill J Gurley; John S Markowitz
Journal:  J Clin Psychopharmacol       Date:  2019 Sep/Oct       Impact factor: 3.153

Review 6.  Opioid complications and side effects.

Authors:  Ramsin Benyamin; Andrea M Trescot; Sukdeb Datta; Ricardo Buenaventura; Rajive Adlaka; Nalini Sehgal; Scott E Glaser; Ricardo Vallejo
Journal:  Pain Physician       Date:  2008-03       Impact factor: 4.965

7.  Opioid-induced myoclonus and hyperalgesia following a short course of low-dose oral morphine.

Authors:  Owen Bleddyn Woodward; Sangeeta Naraen; Akriti Naraen
Journal:  Br J Pain       Date:  2016-08-22

8.  Codeine Precipitating Serotonin Syndrome in a Patient in Therapy with Antidepressant and Triptan.

Authors:  Giulia Milano; Werner Maria Natta; Alfredo Bello; Antonietta Martelli; Francesca Mattioli
Journal:  Clin Psychopharmacol Neurosci       Date:  2017-08-31       Impact factor: 2.582

Review 9.  Cannabinoid Delivery Systems for Pain and Inflammation Treatment.

Authors:  Natascia Bruni; Carlo Della Pepa; Simonetta Oliaro-Bosso; Enrica Pessione; Daniela Gastaldi; Franco Dosio
Journal:  Molecules       Date:  2018-09-27       Impact factor: 4.411

10.  Opioid prescribing for chronic musculoskeletal pain in UK primary care: results from a cohort analysis of the COPERS trial.

Authors:  Tomi Ashaye; Natalia Hounsome; Dawn Carnes; Stephanie J C Taylor; Kate Homer; Sandra Eldridge; Anne Spencer; Anisur Rahman; Jens Foell; Martin R Underwood
Journal:  BMJ Open       Date:  2018-06-06       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.